CompletedPhase 3

Amniotic Membrane Treatment for Hyposecretory Dry Eye

Argentina37 participantsStarted 2019-02-01

Plain-language summary

The goal of this randomized, active-controlled, parallel-group trial is to evaluate the clinical efficacy of amniotic membrane extract eye drops (AMEED) in reducing signs and symptoms of hyposecretory dry eye Participants will receibed amniotic membrane extract eye drops 6 times daily and was evaluated at baseline day and day 30th. Researchers will compare against autologous serum eye drops effects

Who can participate

Age range21 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 21 years of age or older * dry eye related symptoms * Fluorescein Corneal Staining score of 4 or more * Lisamina Green Conjunctival score of 4 or more * a no-anesthesia Schirmer test value at 5' of 10 mm or less Exclusion Criteria: * glaucoma treatment * surgical procedures within 3 months of the baseline evaluation * precense of punctal plug * patients that were human immunodeficiency virus positive

What they're measuring

Lisamina green conjunctival staining

Timeframe: 1 month

Trial details

NCT IDNCT05598242

SponsorHospital Nacional Profesor Alejandro Posadas

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-01

View on ClinicalTrials.gov More Dry Eye Syndromes trials